amgen astellas biopharma
Verified Intelhttp://www.aabp.co.jp/jp/201310 40020132020 ---- Amgen Astellas BioPharma K.K.http://www.aabp.co.jp/jp/ is a Japanese company that began operations on October 1, 2013, to provide breakthrough-science-based medicines to help address unmet medical needs of patients in Japan. The company is a joint venture between Amgen, one of the worlds leading independent biotechnology companies, and Astellas Pharma Inc., a leading Tokyo-based R&D oriented global pharmaceutical company. AABP has grown into an organization with over 400 employees and comprehensive functions to be fully operational as a marketing authorization holder in Japan. The joint venture will become a wholly-owned Amgen affiliate as soon as 2020.
http://www.aabp.co.jp/jp/201310 40020132020 ---- Amgen Astellas BioPharma K.K.http://www.aabp.co.jp/jp/ is a Japanese company that began operations on October 1, 2013, to provide breakthrough-science-based medicines to help address unmet medical needs of patients in Japan. The company is a joint venture between Amgen, one of the worlds leading independent biotechnology companies, and Astellas Pharma Inc., a leading Tokyo-based R&D oriented global pharmaceutical company. AABP has grown into an organization with over 400 employees and comprehensive functions to be fully operational as a marketing authorization holder in Japan. The joint venture will become a wholly-owned Amgen affiliate as soon as 2020.
Corporate Firmographics
Entity classification and operating profile
- Industry
- Pharmaceuticals
- Company Type
- Privately Held
- Founded
- Undisclosed
- Employee Bracket
- 51-200
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- 1-7-12 Marunouchi Tokyo Chiyoda-ku
- City
- Tokyo
- Region / State
- Tokyo
- Postal Code
- 100-0005
- Country
- Japan
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for amgen astellas biopharma.